1. Home
  2. NHC vs HAE Comparison

NHC vs HAE Comparison

Compare NHC & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National HealthCare Corporation

NHC

National HealthCare Corporation

HOLD

Current Price

$157.70

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$56.29

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NHC
HAE
Founded
1971
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
NHC
HAE
Price
$157.70
$56.29
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$85.38
AVG Volume (30 Days)
85.2K
641.6K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
1.60%
N/A
EPS Growth
17.46
44.54
EPS
7.67
2.46
Revenue
$1,517,781,000.00
$910,373,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.31
P/E Ratio
$20.79
$22.90
Revenue Growth
16.09
N/A
52 Week Low
$89.14
$47.32
52 Week High
$174.54
$87.32

Technical Indicators

Market Signals
Indicator
NHC
HAE
Relative Strength Index (RSI) 46.65 35.76
Support Level $153.40 $55.95
Resistance Level $171.47 $56.64
Average True Range (ATR) 4.84 1.57
MACD -0.53 -0.14
Stochastic Oscillator 30.36 34.75

Price Performance

Historical Comparison
NHC
HAE

About NHC National HealthCare Corporation

National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: